Broad discussion is needed to chart a path forward.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.ads9158 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Severe corneal manifestations of graft-versus-host disease: experience of a tertiary referral center.
Ocul Surf
December 2024
Department of Prof. Cochereau, A. De Rothschild Foundation Hospital, Paris, France. Electronic address:
Purpose: Graft-versus-host disease (GVHD) is a common complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). GVHD may affect several organs, including ocular manifestations, ranging from dry eye syndrome to sight-threatening corneal ulceration or perforation. Limited information is available about characteristics and treatments of ocular GVHD and its relation to general prognosis.
View Article and Find Full Text PDFMultimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data.
J Glob Health
December 2024
Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Background: Shanghai's high level of ageing has given rise to a considerable number of elderly patients with type 2 diabetes mellitus (T2DM) who are confronted with the challenge of managing multimorbidity. We aimed to determine the prevalence of multimorbidity in elderly T2DM patients in a representative Pudong New Area community and critically evaluate current guidelines' inclusiveness in addressing major comorbidities.
Methods: Through the Shanghai Health Cloud platform, we extracted medical records of residents in the Huamu community (Pudong New Area, Shanghai) to screen elderly patients with at least three outpatient visits or one hospitalisation per year between 2019 and 2022.
Resuscitation, yes or no ? the criteria for transferring patients with hematological malignancies to intensive care. A qualitative study.
BMC Palliat Care
December 2024
Palliative Care Unit, Louise Michel Hospital, Clermont-Ferrand University Hospital, 54 rue Montalembert BP69, Clermont-Ferrand, Cedex 1, Clermont-Ferrand, 63003, France.
Background: Having a hematological malignancy increases the risk of a poor-quality end of life and of dying in intensive care. There is no prognostic score to predict survival on admission to intensive care, but many patients die there. To identify the criteria used in deciding to transfer patients with hematological malignancies to intensive care.
View Article and Find Full Text PDFRisk management in Moroccan public hospitals: a literature review.
Int J Health Care Qual Assur
December 2024
Research Team: "Marketing-Management-Employability-Entrepreneurship and Innovation" (2M2EI), Polydisciplinary Faculty of Beni Mellal, Poly-Disciplinary Research Laboratory in Economics and Management (LRPEG), University Sultan Moulay Slimane, Béni Mellal, Morocco.
Purpose: The objective of this review is to provide a comprehensive analysis of risk management practices in the healthcare sector, with a particular focus on identifying challenges and strategies in Moroccan hospitals.
Design/methodology/approach: A literature search was carried out on several academic search engines using search terms reflecting the relationship between risk management and public hospitals in Morocco.
Findings: The Moroccan public hospital is confronted with several disjunctions, which can be sources of multiple risks.
Practical Application of Nirsevimab Recommendations for Infants and Toddlers.
J Pediatr Health Care
December 2024
Respiratory syncytial virus (RSV) is a common respiratory tract infection that causes bronchiolitis and pneumonia in infants and children. It is the leading cause of hospitalization of infants in the United States. Nirsevimab is a long-acting monoclonal antibody recommended for the prevention of severe disease in all infants under 8 months of age and certain high-risk toddlers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!